| | FDA Grants IND for Pro-Pharmaceuticals’ DAVANAT ® to Treat Breast ... - Business Wire (press release)

FDA Grants IND for Pro-Pharmaceuticals’ DAVANAT ® to Treat Breast ... - Business Wire (press release)

FDA Grants IND for Pro-Pharmaceuticals’ DAVANAT ® to Treat Breast ... Business Wire (press release), CA - 18 hours ago DAVANAT ® also is being administered in Phase II clinical trials for first-line treatment of colorectal and biliary cancer patients. ... FDA Grants IND Application for Pro-Pharmaceuticals's Davanat RedOrbit all 15 news articles

Click Here to read the entire article...